Skip to main content

CITADEL ADVISORS LLC

Position in LENZ — LENZ Therapeutics, Inc.

CIK 1423053 MIAMI, FL

Position in LENZ

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
-$1,289,184 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2025
5 quarters on record

Common Shares in LENZ Over Time

Shares Held

Position Value (USD)

Derivatives in LENZ

reported options exposure · as of Mar 31, 2026
CallValue
$688,995
CallShares
75,300
PutValue
$717,360
PutShares
78,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,780,363,972 across 373 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in LENZ

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $717,360 78,400
2026-03-31 $688,995 75,300
2025-12-31 $318,400 19,900
2025-12-31 $1,313,600 82,100
2025-12-31 $1,289,184 80,574
2025-09-30 $670,752 14,400
2025-09-30 $18,605,449 399,430
2025-09-30 $1,159,842 24,900
2025-06-30 $264,874 9,037
2025-06-30 $304,824 10,400
2025-03-31 $246,661 9,594